What Blankemeier built was not a company with an exit strategy — it was a delivery vehicle for research that could not reach patients any other way. Cognita's AI interpreted medical images across a diagnostic breadth that , but diagnostic breadth without institutional routing is a capability that sits in a demo environment. Radiology Partners provided the network. The acquisition was the product reaching its intended destination. Healthcare AI founders who treat the independent company as the only legitimate outcome are solving the…